Related Experiment Video

Updated: Mar 3, 2026

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

40.7K

Clarifying complex inheritance: apolipoprotein C3 and atherosclerosis

David J Galton1

  • 1Wolfson Institute of Preventive Medicine, The Royal London and St. Bartholomew's Hospitals, London, UK.

Current Opinion in Lipidology
|April 26, 2017
PubMed
Abstract

Insights

A new drug, volanesorsen, targets apolipoprotein C3 messenger RNA to treat severe hypertriglyceridaemia. This breakthrough offers hope for managing lipid disorders and atherosclerosis risk.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cardiovascular Medicine

Background:

  • Apolipoprotein C3 (ApoC3) plays a key role in lipid metabolism.
  • Gene mutations in ApoC3 influence susceptibility to hyperlipidaemia and atherosclerosis.
  • Understanding ApoC3's molecular biology is crucial for developing targeted therapies.

Purpose of the Study:

  • To review advancements in the molecular biology of apolipoprotein C3.
  • To examine gene mutations associated with hyperlipidaemia and atherosclerosis.
  • To highlight the development of novel therapeutic strategies targeting ApoC3.

Main Methods:

  • Review of scientific literature on apolipoprotein C3.
  • Analysis of genetic data related to ApoC3 mutations.
  • Evaluation of clinical trial data for new therapeutic agents.

Main Results:

  • Identification of key molecular pathways involving apolipoprotein C3.
  • Discovery of genetic variants linked to altered lipid profiles and cardiovascular risk.
  • Development of volanesorsen, a novel therapeutic agent.

Conclusions:

  • Volanesorsen effectively inhibits apolipoprotein C3 mRNA function.
  • Phase 3 trials demonstrate successful treatment of severe hypertriglyceridaemia.
  • Targeting ApoC3 offers a promising therapeutic approach for lipid disorders.

More Related Videos

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.6K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
529
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.6K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
654
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
821
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Inflammation01:38

Inflammation

Overview
62.9K